[Therapeutic options for visceral leishmaniasis].
作者信息
Desjeux P
机构信息
Institute for Oneworld Health (iOWH), 899, rue Jean de Gingins, 01220 Divonne, France.
出版信息
Med Mal Infect. 2005 Jun;35 Suppl 2:S74-6. doi: 10.1016/s0399-077x(05)80887-x.
Abstract
摘要
相似文献
1
[Therapeutic options for visceral leishmaniasis].[内脏利什曼病的治疗选择]
Med Mal Infect. 2005 Jun;35 Suppl 2:S74-6. doi: 10.1016/s0399-077x(05)80887-x.
2
Comment on: leishmaniasis: an update of current pharmacotherapy.关于《利什曼病：当前药物治疗的最新进展》的评论
Expert Opin Pharmacother. 2013 Jun;14(9):1275-6. doi: 10.1517/14656566.2013.795544. Epub 2013 Apr 29.
3
Diffuse cutaneous dissemination of visceral leishmaniasis during human immunodeficiency virus (HIV) infection, despite negligible immunodeficiency: repeated failure of liposomal amphotericin B administration, followed by successful long-term pentamidine and paromomycin administration.尽管免疫缺陷程度可忽略不计，但在人类免疫缺陷病毒（HIV）感染期间仍发生了内脏利什曼病的弥漫性皮肤播散：脂质体两性霉素B给药多次失败，随后成功长期给予喷他脒和巴龙霉素。
Int J Antimicrob Agents. 2008 Jun;31(6):590-2. doi: 10.1016/j.ijantimicag.2008.02.007. Epub 2008 May 5.
4
Recent advances in the treatment of visceral leishmaniasis.内脏利什曼病治疗的最新进展
Trans R Soc Trop Med Hyg. 1993 Mar-Apr;87(2):130-1, 141. doi: 10.1016/0035-9203(93)90457-2.
5
Treatment of visceral leishmaniasis in 2010: direction from Bihar State, India.2010年内脏利什曼病的治疗：来自印度比哈尔邦的指导意见。
Future Microbiol. 2010 Sep;5(9):1301-3. doi: 10.2217/fmb.10.92.
6
Injectable paromomycin for Visceral leishmaniasis in India.印度用于治疗内脏利什曼病的注射用巴龙霉素
N Engl J Med. 2007 Jun 21;356(25):2571-81. doi: 10.1056/NEJMoa066536.
7
Challenges in the management of visceral leishmaniasis.内脏利什曼病管理中的挑战。
Indian Pediatr. 2005 Jun;42(6):523-6.
8
Eliminating visceral leishmaniasis in South Asia: the road ahead.消除南亚内脏利什曼病：前路漫漫。
BMJ. 2019 Jan 22;364:k5224. doi: 10.1136/bmj.k5224.
9
Treatment of visceral leishmaniasis: options and choice.内脏利什曼病的治疗：选择与方案
Lancet Infect Dis. 2016 Feb;16(2):142-3. doi: 10.1016/S1473-3099(15)00528-9. Epub 2016 Jan 26.
10
The treatment of visceral leishmaniasis: safety and efficacy.内脏利什曼病的治疗：安全性与疗效
JNMA J Nepal Med Assoc. 2013 Oct-Dec;52(192):645-51.
引用本文的文献
1
Integrative genomic, proteomic and phenotypic studies of Leishmania donovani strains revealed genetic features associated with virulence and antimony-resistance.对利什曼原虫菌株的综合基因组、蛋白质组和表型研究揭示了与毒力和锑耐药性相关的遗传特征。
Parasit Vectors. 2020 Oct 12;13(1):510. doi: 10.1186/s13071-020-04397-4.
2
[Visceral leishmaniasis in adults: about twelve cases].成人内脏利什曼病：约12例
Pan Afr Med J. 2016 Apr 15;23:194. doi: 10.11604/pamj.2016.23.194.8921. eCollection 2016.
Zotero 插件